Patents by Inventor Steven Burkhead

Steven Burkhead has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INTERLEUKIN-17 RECEPTOR HOMOLOGUE
    Publication number: 20070049729
    Abstract: Cytokines and their receptors have proven usefulness in both basic research and as therapeutics. The present invention provides a new human cytokine receptor designated as “Zcytor14.
    Type: Application
    Filed: October 2, 2006
    Publication date: March 1, 2007
    Inventors: Scott Presnell, Steven Burkhead, Sarah Pownder
  • SOLUBLE ZCYTOR14, ANTI-ZCYTOR14 ANTIBODIES AND BINDING PARTNERS AND METHODS OF USING IN INFLAMMATION
    Publication number: 20070048257
    Abstract: The present invention relates to blocking, inhibiting, reducing, antagonizing or neutralizing the activity of IL-17F, IL-17A, or both IL-17A and IL-17F polypeptide molecules. IL-17A and IL-17F are cytokines that are involved in inflammatory processes and human disease. ZcytoR14 is a common receptor for IL-17A and IL-17F. The present invention includes soluble ZcytoR14, anti-ZcytoR14 antibodies and binding partners, as well as methods for antagonizing IL-17F, IL-17A or both IL-17A and IL-17F using such soluble receptors, antibodies and binding partners.
    Type: Application
    Filed: October 4, 2006
    Publication date: March 1, 2007
    Inventors: Scott Presnell, Steven Burkhead, Steven Levin, Rolf Kuestner, Zeren Gao, Stephen Jaspers, Janine Bilsborough
  • INTERLEUKIN-17 RECEPTOR HOMOLOGUE
    Publication number: 20070048824
    Abstract: Cytokines and their receptors have proven usefulness in both basic research and as therapeutics. The present invention provides a new human cytokine receptor designated as “Zcytor14.
    Type: Application
    Filed: October 2, 2006
    Publication date: March 1, 2007
    Inventors: Scott Presnell, Steven Burkhead, Sarah Pownder
  • SOLUBLE ZCYTOR14, ANTI-ZCYTOR14 ANTIBODIES AND BINDING PARTNERS AND METHODS OF USING IN INFLAMMATION
    Publication number: 20070048826
    Abstract: The present invention relates to blocking, inhibiting, reduceing, antagonizing or neutralizing the activity of IL-17F, IL-17A, or both IL-17A and IL-17F polypeptide molecules. IL-17A and IL-17F are cytokines that are involved in inflammatory processes and human disease. ZcytoR14 is a common receptor for IL-17A and IL-17F. The present invention includes soluble ZcytoR14, anti-ZcytoR14 antibodies and binding partners, as well as methods for antagonizing IL-17F, IL-17A or both IL-17A and IL-17F using such soluble receptors, antibodies and binding partners.
    Type: Application
    Filed: October 4, 2006
    Publication date: March 1, 2007
    Inventors: Scott Presnell, Steven Burkhead, Steven Levin, Rolf Kuestner, Zeren Gao, Stephen Jaspers, Janine Bilsborough
  • INTERLEUKIN-17 RECEPTOR HOMOLOGUE
    Publication number: 20070037969
    Abstract: Cytokines and their receptors have proven usefulness in both basic research and as therapeutics. The present invention provides a new human cytokine receptor designated as “Zcytor14.
    Type: Application
    Filed: October 2, 2006
    Publication date: February 15, 2007
    Inventors: SCOTT PRESNELL, STEVEN BURKHEAD, SARAH POWNDER
  • INTERLEUKIN-17 RECEPTOR HOMOLOGUE
    Publication number: 20070036791
    Abstract: Cytokines and their receptors have proven usefulness in both basic research and as therapeutics. The present invention provides a new human cytokine receptor designated as “Zcytor14.
    Type: Application
    Filed: October 2, 2006
    Publication date: February 15, 2007
    Inventors: Scott Presnell, Steven Burkhead, Sarah Pownder
  • INTERLEUKIN-17 RECEPTOR HOMOLOGUE
    Publication number: 20070037970
    Abstract: Cytokines and their receptors have proven usefulness in both basic research and as therapeutics. The present invention provides a new human cytokine receptor designated as “Zcytor14.
    Type: Application
    Filed: October 2, 2006
    Publication date: February 15, 2007
    Inventors: Scott Presnell, Steven Burkhead, Sarah Pownder
  • INTERLEUKIN-17 RECEPTOR HOMOLOGUE
    Publication number: 20070037965
    Abstract: Cytokines and their receptors have proven usefulness in both basic research and as therapeutics. The present invention provides a new human cytokine receptor designated as “Zcytor14.
    Type: Application
    Filed: October 2, 2006
    Publication date: February 15, 2007
    Inventors: Scott Presnell, Steven Burkhead, Sarah Pownder
  • INTERLEUKIN-17 RECEPTOR HOMOLOGUE
    Publication number: 20070037968
    Abstract: Cytokines and their receptors have proven usefulness in both basic research and as therapeutics. The present invention provides a new human cytokine receptor designated as “Zcytor14.
    Type: Application
    Filed: October 2, 2006
    Publication date: February 15, 2007
    Inventors: Scott Presnell, Steven Burkhead, Sarah Pownder
  • INTERLEUKIN-17 RECEPTOR HOMOLOGUE
    Publication number: 20070036763
    Abstract: Cytokines and their receptors have proven usefulness in both basic research and as therapeutics. The present invention provides a new human cytokine receptor designated as “Zcytor14.
    Type: Application
    Filed: October 2, 2006
    Publication date: February 15, 2007
    Inventors: Scott Presnell, Steven Burkhead, Sarah Pownder
  • Soluble ZcytoR14, anti-ZcytoR14 antibodies and binding partners and methods of using in inflammation
    Publication number: 20060002925
    Abstract: The present invention relates to blocking, inhibiting, reduceing, antagonizing or neutralizing the activity of IL-17F, IL-17A, or both IL-17A and IL-17F polypeptide molecules. IL-17A and IL-17F are cytokines that are involved in inflammatory processes and human disease. ZcytoR14 is a common receptor for IL-17A and IL-17F. The present invention includes soluble ZcytoR14, anti-ZcytoR14 antibodies and binding partners, as well as methods for antagonizing IL-17F, IL-17A or both IL-17A and IL-17F using such soluble receptors, antibodies and binding partners.
    Type: Application
    Filed: June 10, 2005
    Publication date: January 5, 2006
    Inventors: Scott Presnell, Steven Burkhead, Steven Levin, Rolf Kuestner, Zeren Gao, Stephen Jaspers, Janine Bilsborough